Fragile X Syndrome (FXS), also called FX syndrome or Martin-Bell syndrome, is a genetic disorder that affects a child's development, behaviour, appearance, and health. It is the most common inherited ...

GPs are being urged to test patients for a genetic condition that can cause learning disabilities and increase the risk of early menopause. Fragile X Society, the charity leading this call to action, ...

To mark Fragile X awareness day today and the 35th anniversary of the Fragile X Society, Queen’s University and the Fragile X ...

Building on more than two decades of research, a study by MIT neuroscientists at The Picower Institute for Learning and Memory reports a new way to treat pathology and symptoms of fragile X syndrome, ...

Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced topline results from its Phase 3 registrational clinical ...

Research on fragile X syndrome, the most common inherited cause of mental retardation, has focused mostly on how the genetic defect alters the functioning of neurons in the brain. A new study focusing ...

Researchers have developed an innovative new nanopore sequencing assay to identify carriers of fragile X syndrome (FXS), the leading cause of monogenic autism spectrum disorder and inherited ...

A new study shows that enhancing activity of a specific component of 'NMDA' receptors normalizes protein synthesis, neural activity and seizure susceptibility in the hippocampus of fragile X lab mice.

SPG601 is an investigational small molecule large-conductance, calcium-activated potassium channel activator. The Food and Drug Administration (FDA) has granted Fast Track designation to SPG601 for ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Quiver Bioscience (“Quiver”) and QurAlis Corporation (“QurAlis”), today announced that the companies have entered into a research collaboration to advance a novel ...

While Harmony management has not disclosed future plans for ZYN002, Jefferies analysts expect the asset to be shelved.